On July 25, 2022 Komodo Health reported that it will join advocacy leaders at Fight Colorectal Cancer (Fight CRC) and 17 other leading public health institutions and industry leaders at the White House to discuss solutions to improve colorectal cancer care standards in the U.S (Press release, Fight CRC, JUL 25, 2022, View Source [SID1234616913]). The meeting is in response to President Biden’s call to action to improve and increase access to colorectal cancer screening, with a special emphasis on reaching underserved communities and closing gaps in care. The group of advocacy and industry experts will explore policy solutions and public-private partnerships that will advance the President’s Cancer Moonshot goals.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

At the event, Komodo will reinforce its commitment to partnering with patient advocacy and public health leaders to democratize access to patient-level insights on colorectal cancer care. Real-world evidence from Komodo’s Healthcare MapTM can help to identify where screening is needed in order to improve early detection in the communities that need it most. Komodo will use its technology platform to advance more proactive research, investment, and public health guidelines that can meaningfully address standards of care and preventive screenings for colorectal cancer. Komodo’s commitment is in response to President Biden’s renewed Cancer Moonshot initiative, which calls for ambitious goals and solutions to "end cancer as we know it."

"We’re proud to support the President’s Cancer Moonshot Initiative, and deepen the industry’s understanding of exactly when, where, and how patients experience disparities in care," said Arif Nathoo, MD, CEO and Co-Founder, Komodo Health. "We must take a data-driven approach to developing policies that improve healthcare equality and drive better outcomes for all."

Komodo has been working with Fight CRC and other advocacy and industry leaders in the colorectal cancer community for the past several years, leveraging Komodo’s data-driven intelligence to improve earlier detection, identify barriers to screenings, and help patients identify colorectal cancer specialists in their region. Earlier this year, Fight CRC launched its digital tool, the Fight CRC Provider Finder, a user-friendly resource built on Komodo’s Healthcare Map that allows patients and caregivers to more quickly find healthcare providers experienced in colorectal cancer.

Although colorectal cancer is preventable with timely screening and highly treatable if caught early, one in three people are not up to date with colorectal cancer screening. This was exacerbated by the COVID-19 pandemic; a recent analysis by Komodo Health found new CRC diagnoses were down more than 32%. Despite the availability of several safe and effective CRC screening options, CRC remains the No. 2 overall cancer killer in the U.S. Early detection and treatment play a particularly vital role in reducing racial health inequities and improving outcomes for those with CRC.

"We commend the bold vision to fight cancer by President Biden and the Moonshot program," said Anjee Davis, President of Fight CRC. "It is our hope as catalysts for the colorectal cancer community that with this meeting, we can address inequities within colorectal cancer screening and make progress toward our Path to a Cure. Prevention plays a huge role in ending colorectal cancer. The White House asked for a plan to get more people screened, and we are here to deliver — leading with the power of the patient voice."

Participants who will be attending the White House Meeting:

Carolyn "Bo" Aldigé — Prevent Cancer Foundation, Founder
Alexey Aleshin, MD, MBA — Natera, General Manager, Early Cancer Detection
Andrew Barnell, MBA — Geneoscopy Inc., CEO and Co-Founder
Danielle Carnival, PhD — White House Cancer Moonshot, Coordinator
Austin Chiang, MD, MPH — Medtronic, CMO Gastrointestinal
Kevin Conroy — Exact Sciences, Chairman and CEO
Erin Darbouze, MPH — Fight Colorectal Cancer, Health Policy Manager
Anjee Davis, MPPA — Fight Colorectal Cancer, President
Richard Goldberg, MD — Fight Colorectal Cancer, Board Member
Greg Hamilton, MBA — Epigenomics, CEO
Lisa Lacasse, MBA — American Cancer Society Cancer Action Network (ACS CAN), President
David Lieberman, MD, AGAF — American Gastroenterological Association, Former President
Molly McDonnell — Fight Colorectal Cancer, Director of Advocacy
Arif Nathoo, MD, MPA — Komodo Health, Co-Founder and CEO
Angela Nicholas, MD — Fight Colorectal Cancer, Board Chair
Mike Nolan, MBA — Freenome, CEO
AmirAli Talasaz, PhD — Guardant Health, Co-Founder and Co-CEO
Catharine Young, PhD — Assistant Director for Cancer Moonshot Engagement and Policy